Digital Health Today 360 with Dan Kendall Digital Health Today

I’m glad to be back on the mic and bringing you this special episode of Digital Health Today 360. Why is this episode special? Let me explain.

One of the goals of the Digital Health Today channel is to create a space where people can learn about great innovation that can improve the health of both individuals and entire populations. 

Over the years, as I’ve been creating my own show, I’ve also had the opportunity to expand and serve the health community in other ways. Along with my colleagues at Mission Based Media, we’ve created other audio-first resources to share more information. For example, we created Health Podcast Network to showcase other high-quality, human-centered and evidence-based podcasts. Health Podcast Network now has about 100 different health podcasts and 13,000 episodes. 

We also worked through the pandemic to add new shows to Digital Health Today such as the DTx Podcast with Eugene Borukhovich, where he dives into the nascent digital therapeutics industry.

And, most recently, we launched a library of podcasts called Health Unmuted where we create and share short-format, narrated, audio stories to help people understand more about specific health conditions. We launched the proof-of-concept miniseries last year called COPD Podcast. In June we launched the 5-part miniseries about Alzheimer’s Disease, and this month, in July, we’ll launch a 7-part miniseries about Parkinson’s disease.

Why am I explaining all this? Because all this work at the intersection of health and podcasting has given me a chance to experiment with different formats, styles, content and audiences, and it’s also made me realize that I love creating this show.  

It’s also made me more aware than ever that there is so much more that needs to be shared.  

So, in this special episode, as I fire up the recording studio and prepare some great conversations with guests over the coming weeks and months, I thought I’d stand aside and invite another podcaster who is doing some great work in an area that needs much more attention.  

Georgie Kovacs is the founder and host of Fempower Health - the go-to resource for all things women’s health serving women, their providers, and companies looking to build and improve on products for women. Georgie is really open about her first-hand experience with infertility and endometriosis. With that experience, she was motivated to start a podcast - in the middle of COVID, and as a single parent. Now if that’s not passion, I don’t know what is.

You can find her show, Fempower Health, on Health Podcast Network.

In this special episode, Georgie spoke with Dr. Michal Elovitz. Dr. Elovitz is the Distinguished Professor in Women’s Health at the Perelman School of Medicine at the University of Pennsylvania and she’s also the Chief Medical Advisor at Mirvie, a company creating a personalized window into pregnancy health.  

When it comes to women’s health, I’ve been astonished at the tremendous need for improvement, funding and resources, and at the same time, I’ve also seen some incredible innovation that is happening that needs more attention, awareness and funding!

And despite the U.S. having the highest maternal mortality rate among developed countries, health risks in pregnancy health have remained understudied, underfunded, and underserved. Pregnancy complications such as preeclampsia, preterm birth and gestational diabetes impact 1 in 5 women, and with no accurate way to predict them before symptoms appear, both moms and babies are often in crisis mode when diagnosed in their third trimester. 

In their conversation, Georgie and Dr. Elovitz explain one of those complications, preeclampsia, and explore how better screening can help.

Let me know what you think of this episode. Drop me a line on Twitter or LinkedIn and let me know!

More great episodes of DHT360 are on the way, so be sure to hit follow on your favorite podcast app.  

Thanks for tunin

Technology is under the microscope, as are the behaviors of the people who develop and deploy it.

As technology impacts virtually every aspect of society, it's use within the life sciences goes beyond traditional bioethical topics. 

This creates a host of questions for people and businesses working at the forefront of health innovation.

In this episode, hear Nick Bott, Global Head, Bioethics and Technology Ethics at Takeda as we discuss:

What is being done to ensure that the decisions around the use of technology for our health and wellbeing are carefully considered and applied? 

Whose job is it to address the ethical questions in the development of AI and ML algorithms? 

How can life science companies lead the way in setting standards for ethical development?

What can we learn from Tony Stark - otherwise known as Iron Man in the Marvel Cinematic Universe?

What is a 'consequence scanning workshop'?

What is the role of regulation in setting standards and principles?


Episode Links and Resources:

Learn More About Ethics and Compliance at Takeda


Notre Dame-IBM Technology Ethics Lab

Markkula Center for Applied Ethics at Santa Clara University

About the Age of Ultron - a lesson in 'irresponsible innovation'?

Hear the Coffee Talk about the Health Outcomes Observatory (H2O)



Guest Host Links
Connect with Nick Bott on LinkedIn


Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Roche

Takeda

Guest host Sophie Park interviews health economist Jane Sarasohn-Kahn for this fast-paced discussion about women's health, social determinants of health and the 'she-cession' in the wake of the COVID-19 pandemic.
We've seen the headlines during COVID-19: Rising caseloads. Millions of lives lost. Economic devastation. Schools closed.
But these only tell part of the story.
The impact of the pandemic on mental and physical health extends far beyond those that are directly infected with the disease.
Delayed diagnosis, canceled or delayed treatment, loss of employment and the collision of home and professional responsibilities has had a tremendous and long-lasting impact.
Join Jane Sarasohn-Kahn and guest host Sophie Park in this discussion about the affects of the pandemic.
For more discussion about women's health, check out the video panel with Jane and Sonia Millsom, Chief Commercial Officer of Maven Clinic, on the September 9 Digital Health Forum.

Episode Links and Resources:

Connect with Jane Sarasohn-Kahn: Website | Twitter | LinkedIn |

Attend Digital Health Forum: Website | LinkedIn | Twitter


Tune into Episode 16 with Kate Ryder, founder of Maven Clinic


Guest Host Links


Twitter @sophiemariepark


Linkedin: https://www.linkedin.com/in/sophiemariepark/


Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Roche

Takeda

Every day, tech companies and governments frame the conversation around the use of data. With the proliferation of smartphones and wearable devices, online shopping, and home voice assistants, we leave a digital footprint with almost everything we do.
While our data can be crunched to drive better insights on listening habits, activity levels, and consumer preferences. There's also a far more important application for our data: to improve human lives and health outcomes. 
In this coffee talk, we explore how leaders in the pharmaceutical industry are working with people, policy makers and providers to create solutions that will usher in a new era of healthcare solutions and services.
This Coffee Talk is created with support from Takeda.
Guest Links and Resources:

Connect with Meni Styliadou: LinkedIn


Connect with Takeda: Website | Twitter | LinkedIn


Connect with H2O: Website | Twitter | LinkedIn | YouTube


European Patient Forum: Website


Innovative Medicines Initiative: Website | Twitter | LinkedIn | YouTube



Host Links
Connect with Dan: Twitter | LinkedIn


Connect on Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services.
Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care.
One of those organizations is Bayer.
In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy.

This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases.  
The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today.
The deadline to apply is June 20, 2021.

Guest Links and Resources:

Connect with Dom Kennerson: Twitter | LinkedIn


Connect with Bayer G4A: Website | Twitter | LinkedIn | YouTube


World Health Organization - Website | Constitution



Host Links
Connect with Dan: Twitter | Linkedin


Connect on Digital Health Today:
Browse Episodes | Twitter | Linkedin | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Dr. David E Albert is a physician, engineer, inventor and serial entrepreneur, and he's the founder and Chief Medical Officer of Alivecor. Dr. Albert has developed life-saving technologies and products for more than 30 years, and he's turned a number of those inventions into tech startups, even before it was a trendy thing to do.
Each year, over 20,000 students enrolled in medical schools across the US.
Over 600,000 businesses are started each year in the US, and nearly half fail within five years; two-thirds fail within 10 years.
So why do people who are on a path to a successful career in medicine decide to become entrepreneurs?
Dr. Albert says that "a lot of people go into medicine because it's not very risky. And so there's a real juxtaposition between those people who go into medicine because it's a secure professional lifestyle, and being an entrepreneur."
Back in January, 2011, Dr. Albert posted a four minute YouTube video showing how to turn an apple iPhone 4 into a wireless clinical quality cardiac event recorder. It's called AliveCor, and it looked like magic. Ten years later, the AliveCor company continues to grow and expand.
Tune into this special episode as we highlight the twists of fate and deliberate decisions that shaped Dr. Albert's career, and hear how his work and companies continue to make a lasting impact in the delivery of care.

Guest Links and Resources:

Connect with Dr. Dave Albert: Twitter | LinkedIn |

Connect with AliveCor: Website | Twitter | LinkedIn | YouTube


Dr. Albert's 2011 YouTube video showing the AliveCor ECG



Host Links


Twitter @healthtechdan


Linkedin: https://www.linkedin.com/in/dankendall/


Connect on Digital Health Today:
Browse Episodes | Twitter | Linkedin | Facebook | Instagram

Connect on Health Podcast Network:
Browse Shows | Linkedin | Twitter | Facebook | Instagram

Digital Health Today is made possible by the support of our sponsors. Thank you to:

Bayer G4A

Cedars-Sinai Accelerator

Roche

Takeda